Overview

A Study to Evaluate the Safety and Effectiveness of FK778 in Liver Transplant Patients

Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
A proof of concept study to evaluate the safety and effectiveness of FK778 in liver transplant patients.
Phase:
Phase 2
Details
Lead Sponsor:
Astellas Pharma Inc